Two cardamonin analogs, 4,4′-dihydroxylchalcone, 17, and 4,4′-dihydroxy-2′-methoxychalcone, 18 (Figure 6), were found to suppress the activation of NF-κB pathway in lung cancer cells. The gene discussed is NFKB1; the disease is lung cancer.